Business News

Pfizer and Moderna will improve the worth of their vaccines as they adapt to new variants

According to the Financial Times, this will happen in the European Union and is likely to be the case with the rest of the buyers as well.

Expand your business,
Not your inbox

Stay informed and subscribe to our daily newsletter now!

August
2, 2021

Read for 2 minutes

This article was translated from our Spanish edition using AI technologies. Errors can occur because of this process.

Pharmaceutical companies Pfizer and Moderna will increase the price of their respective vaccines after adapting to new variants of the COVID-19 virus. According to El Economista, this was confirmed by the French State Secretary for European Affairs, Clément Beaune, to the Financial Times.

What will the new prices be?

According to the British newspaper, the price of Pfizer's vaccine will range from 15.50 euros (about 366.10 Mexican pesos) to 19.50 euros (about 460.58 Mexican pesos), while that of Moderna will range from 19 euros (448 euros). 77 Mexican pesos) will rise. approximately) at 21.50 euros (507.81 Mexican pesos).

As the official explained, this should be viewed with reason … have more demanding contracts with variant-adapted products, not just for the European Union (EU) but for all buyers.

Image: Luis Alvarez / DigitalVision via Getty Images

In December 2020, pharmaceutical developers like Pfizer and Moderna made around $ 32 billion from the vaccine.

According to Morgan Stanley, Pfizer would generate $ 19 billion in vaccine revenue this year, on top of an estimated $ 975 million in vaccines in 2020.

Related Articles